Morgan Stanley’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.9M | Buy |
|
|||||
|
2025
Q1 | $21.3M | Sell |
|
|||||
|
2024
Q4 | $24.5M | Sell |
|
|||||
|
2024
Q3 | $22.6M | Buy |
|
|||||
|
2024
Q2 | $17.9M | Buy |
|
|||||
|
2024
Q1 | $22.2M | Sell |
|
|||||
|
2023
Q4 | $41.9M | Buy |
|
|||||
|
2023
Q3 | $14.6M | Sell |
|
|||||
|
2023
Q2 | $16.7M | Buy |
|
|||||
|
2023
Q1 | $19.6M | Sell |
|
|||||
|
2022
Q4 | $26.1M | Buy |
|
|||||
|
2022
Q3 | $17.5M | Buy |
|
|||||
|
2022
Q2 | $13.7M | Buy |
|
|||||
|
2022
Q1 | $7.52M | Sell |
|
|||||
|
2021
Q4 | $8.11M | Buy |
|
|||||
|
2021
Q3 | $6M | Sell |
|
|||||
|
2021
Q2 | $8.1M | Buy |
|
|||||
|
2021
Q1 | $5.1M | Sell |
|
|||||
|
2020
Q4 | $5.75M | Sell |
|
|||||
|
2020
Q3 | $8.42M | Sell |
|
|||||
|
2020
Q2 | $14.7M | Sell |
|
|||||
|
2020
Q1 | $20.5M | Buy |
|
|||||
|
2019
Q4 | $25.5M | Buy |
|
|||||
|
2019
Q3 | $9.49M | Buy |
|
|||||
|
2019
Q2 | $10.6M | Sell |
|
|||||
|
2019
Q1 | $13.6M | Sell |
|
|||||
|
2018
Q4 | $17.9M | Buy |
|
|||||
|
2018
Q3 | $19.5M | Sell |
|
|||||
|
2018
Q2 | $28.5M | Buy |
|
|||||
|
2018
Q1 | $9.77M | Sell |
|
|||||
|
2017
Q4 | $9.04M | Buy |
|
|||||
|
2017
Q3 | $8.73M | Sell |
|
|||||
|
2017
Q2 | $17.7M | Buy |
|
|||||
|
2017
Q1 | $10.9M | Sell |
|
|||||
|
2016
Q4 | $12.9M | Buy |
|
|||||
|
2016
Q3 | $8.23M | Sell |
|
|||||
|
2016
Q2 | $11.1M | Sell |
|
|||||
|
2016
Q1 | $8.61M | Sell |
|
|||||
|
2015
Q4 | $7.74M | Buy |
|
|||||
|
2015
Q3 | $6.14M | Buy |
|
|||||
|
2015
Q2 | $6.47M | Buy |
|
|||||
|
2015
Q1 | $460K | Sell |
|
|||||
|
2014
Q4 | $1.57M | Buy |
|
|||||
|
2014
Q3 | $475K | Sell |
|
|||||
|
2014
Q2 | $810K | Sell |
|
|||||
|
2014
Q1 | $2.73M | Buy |
|
|||||
|
2013
Q4 | $1.11M | Buy |
|
|||||
|
2013
Q3 | $435K | Sell |
|
|||||
|
2013
Q2 | $410K | Buy |
|